INDICATORS ON CLINICAL TRIAL RECRUITMENT FOR ABBV-744 STUDY YOU SHOULD KNOW

In Phase A, members will obtain various doses and schedules of oral ABBV-744 pill to detect Harmless dosing regimen. Additional contributors are going to be enrolled within the determined monotherapy dosign program. In Section B, participants will get oral ruxolitinib and ABBV-744 is going to be provided as "include-on" therapy. In Phase C, individ